Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 11:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1801–1824 of 8,691 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Choroidal Neovascularization, Diabetic Retinopathy, Diabetic Macular Edema
Interventions: PF-04523655 (Stratum I), ranibizumab, PF-04523655 (Stratum II); Drug
Lead sponsor: Quark Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 258 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 20
States / cities: Phoenix, Arizona • Arcadia, California • Beverly Hills, California + 17 more

Conditions: Osteoarthritis, Pain
Interventions: Exparel, Femoral Nerve Block Bupivacaine, Toradol, Morphine Sulfate; Drug
Lead sponsor: The New England Baptist Hospital; Other
Eligibility: 18 Years to 73 Years
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Blepharospasm
Interventions: incobotulinumtoxinA (Xeomin), Placebo; Drug
Lead sponsor: Merz Pharmaceuticals GmbH; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cancer, Rectal
Interventions: Short course radiation therapy; Radiation
Lead sponsor: University of Rochester; Other
Eligibility: 70 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Atopic Dermatitis
Interventions: Lebrikizumab-lbkz; Biological
Lead sponsor: Forefront Dermatology S.C; Other
Eligibility: 12 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 10
States / cities: Mobile, Alabama • Crest Hill, Illinois • Libertyville, Illinois + 7 more

Conditions: Pancreatic Cancer, Esophageal Cancer, Gastric Cancer
Interventions: Nutritional Intervention, Physical Activity Intervention; Combination Product · Behavioral
Lead sponsor: Siobhan Trotter; Other
Eligibility: 25 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Prostate Cancer
Interventions: No Intervention; Other
Lead sponsor: Janssen Scientific Affairs, LLC; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 20
States / cities: Homewood, Alabama • La Mesa, California • Wheat Ridge, Colorado + 17 more

Conditions: Hidradenitis Suppurativa
Interventions: Long-pulsed Nd:YAG laser 1064 nm; Procedure
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Child Development, Child Behavior, Child Abuse, Child Neglect, Parenting, Delinquency, Criminal Behavior
Interventions: home visiting; Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 1 Month to 3 Months
Enrollment: 343 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2038
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Hyperkalemia
Interventions: Not listed
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 1,331 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 17
States / cities: Huntsville, Alabama • La Jolla, California • Rancho Cucamonga, California + 14 more

Conditions: Nephrostomy
Interventions: No flushing of the nephrostomy, Flushing of nephrostomy; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cataract
Interventions: enVista Aspire EA IOLs; Device
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 22 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 7
States / cities: Dover, New Jersey • Woodland Park, New Jersey • Garden City, New York + 4 more

Conditions: Oocyte Cryopreservation
Interventions: Not listed
Lead sponsor: EMD Serono; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 204 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 15
States / cities: Fountain Valley, California • Laguna Hills, California • Newport Beach, California + 11 more

Conditions: Breast Carcinoma
Interventions: Ultrasonography; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Liver Cirrhosis, Acute Kidney Injury, Hepatorenal Syndrome
Interventions: Crystalloids, albumin, vasoconstrictors, diuretics, renal replacement therapy; Combination Product
Lead sponsor: Azienda Ospedaliera di Padova; Other
Eligibility: 18 Years and older
Enrollment: 1,456 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 5
States / cities: Indianapolis, Indiana • New Orleans, Louisiana • Boston, Massachusetts + 2 more

Conditions: Bladder Cancer, Urothelial Carcinoma Bladder
Interventions: Not listed
Lead sponsor: Pangea Laboratory LLC; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Infertility, Mosaicism, Aneuploidy
Interventions: Not listed
Lead sponsor: Inception Fertility Research Institute, LLC; Industry
Eligibility: Female only
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Multiple Myeloma
Interventions: Revlimid; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure Acute, Cardiovascular Diseases
Interventions: Metolazone Oral Tablet, Chlorothiazide Injection; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Neoplasms
Interventions: Semi-structured interview, Developed survey completion, Systems of Belief Inventory (SBI-15R); Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Dialysis Catheter Fibrin Sheath, Clotted Dialysis Catheter, Catheter Malfunction
Interventions: TPA Infusion; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hernia, Pain, Postoperative, Abdominal Wall Relaxation After Rectus Sheath Block
Interventions: Bupivacaine, Normal Saline; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Spinal Deformity
Interventions: Document intraoperative Maneuvers; Procedure
Lead sponsor: AO Foundation, AO Spine; Other
Eligibility: 10 Years to 80 Years
Enrollment: 592 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 5
States / cities: San Francisco, California • Minneapolis, Minnesota • New York, New York + 2 more

Conditions: Amputation, Hyperhidrosis
Interventions: glycopyrronium cloths, Placebo; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Murray, Utah

Search by objective public record fields.

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Femoral Nerve Block Compared to Exparel in Total Knee Replacement

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm

Study of Short Course Radiation Therapy for Elderly Patients With Rectal Cancer

AD Treatment Optimization With Ebglyss in Real-World Practice: A Multicenter Study of Patient-Centered Outcomes

HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa

Catholic Health Initiatives (CHI) St. Joseph's Children Home Visiting Longitudinal Study

Tracking Treatment Pathways in Adult Patients With Hyperkalemia.

Efficacy of Routine Saline Flushing in the Prevention of Nephrostomy Tube Obstructions: A Pilot Study

A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction

Oocyte Cryopreservation Registry (HOPE Registry)

Comparing the Performance of Automated Breast Ultrasonography to Hand-Held Whole Breast Ultrasonography in Breast Cancer Treatment Response Assessment

International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project

Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases

Non-Euploid Embryo Transfer (NEET) Registry

UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma

Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance

Study to Identify and Measure the Values and Palliative Care Pref. of Hindu Patients and Their Caregivers

Rt-PA Infusion Versus Catheter Exchange for Dialysis Catheter Malfunction Due to Fibrin Sheath

Pilot Study: Rectus Sheath Blocks for Improving Abdominal Surgery Conditions

Spinal Deformity Intraoperative Monitoring.

Qbrexza Cloths for Hyperhidrosis of Amputation Sites